Long-time survivors
METASTASES
In our patient collective, there were ten patients who lived longer than two years. These mostly had no distant metastases, only one had metastases at diagnosis and two other patients developed metastases in the course of the treatment.All of these patients underwent surgery, three with complete resection and five with R2, for two patients the resection status was unknown. All long-time survivors received radiotherapy except one. The median total dose was 62.7 Gy.